| Nome |
# |
|
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides, file dd9e0b32-5942-709e-e053-3705fe0a83fd
|
1.422
|
|
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC), file dd9e0b32-6245-709e-e053-3705fe0a83fd
|
1.414
|
|
Biomarkers for the diagnosis and management of heart failure: New frontiers, file dd9e0b32-5cca-709e-e053-3705fe0a83fd
|
737
|
|
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform, file dd9e0b31-c19a-709e-e053-3705fe0a83fd
|
550
|
|
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea, file dd9e0b31-e160-709e-e053-3705fe0a83fd
|
376
|
|
Low triiodothyronine and exercise capacity in heart failure, file dd9e0b31-bf0b-709e-e053-3705fe0a83fd
|
370
|
|
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis, file dd9e0b31-dbbb-709e-e053-3705fe0a83fd
|
335
|
|
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques., file dd9e0b31-c18c-709e-e053-3705fe0a83fd
|
309
|
|
Vericiguat for Heart Failure with Reduced Ejection Fraction, file dd9e0b32-6247-709e-e053-3705fe0a83fd
|
296
|
|
Prognostic value of plasma Renin activity in heart failure., file dd9e0b31-f92b-709e-e053-3705fe0a83fd
|
281
|
|
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure., file dd9e0b31-bc48-709e-e053-3705fe0a83fd
|
272
|
|
Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity, file dd9e0b32-6155-709e-e053-3705fe0a83fd
|
258
|
|
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC)., file dd9e0b31-cc63-709e-e053-3705fe0a83fd
|
256
|
|
Imaging predictors of incident heart failure: a systematic review and meta-analysis, file dd9e0b32-6301-709e-e053-3705fe0a83fd
|
232
|
|
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure., file dd9e0b31-dbbc-709e-e053-3705fe0a83fd
|
227
|
|
Prognostic value of serum gamma-glutamyl transferase activity after
myocardial infarction., file dd9e0b31-bf39-709e-e053-3705fe0a83fd
|
215
|
|
The potential roles of gamma-glutamyltransferase activity in the progression of atherosclerosis and cardiovascular diseases., file dd9e0b31-baf0-709e-e053-3705fe0a83fd
|
212
|
|
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice, file dd9e0b31-da3b-709e-e053-3705fe0a83fd
|
204
|
|
Fractions of plasma gamma-glutamyltransferase in healthy individuals: Reference values., file dd9e0b31-bea2-709e-e053-3705fe0a83fd
|
200
|
|
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases., file dd9e0b31-baef-709e-e053-3705fe0a83fd
|
190
|
|
Sex-related differences in ventricular remodeling after myocardial infarction, file dd9e0b32-5c1e-709e-e053-3705fe0a83fd
|
188
|
|
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study, file dd9e0b31-e129-709e-e053-3705fe0a83fd
|
187
|
|
Thromboembolism and bleeding in systemic amyloidosis: a review, file dd9e0b32-5c1c-709e-e053-3705fe0a83fd
|
184
|
|
The paradox of low BNP levels in obesity, file dd9e0b31-bff2-709e-e053-3705fe0a83fd
|
174
|
|
Markers of fibrosis, inflammation, and remodeling pathways in heart failure, file dd9e0b31-d0b6-709e-e053-3705fe0a83fd
|
160
|
|
Aerobic training decrease B-type natriuretic peptide expression and adrenergic activation in patients with heart failure., file dd9e0b31-fc1f-709e-e053-3705fe0a83fd
|
160
|
|
Forme molecolari della gamma-glutammiltransferasi: caratteristiche e biogenesis., file dd9e0b31-c03e-709e-e053-3705fe0a83fd
|
153
|
|
Overlapping Effects of miR-21 Inhibition and Drugs for Idiopathic Pulmonary Fibrosis: Rationale for Repurposing Nintedanib as a Novel Treatment for Ischemia/Reperfusion Injury, file dd9e0b32-633b-709e-e053-3705fe0a83fd
|
144
|
|
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure, file dd9e0b32-633d-709e-e053-3705fe0a83fd
|
144
|
|
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides, file dd9e0b31-c187-709e-e053-3705fe0a83fd
|
139
|
|
Research protocol for the validation of a new portable technology for real-time continuous monitoring of Early Warning Score (EWS) in hospital practice and for an early-stage multistakeholder assessment, file dd9e0b32-4ab5-709e-e053-3705fe0a83fd
|
138
|
|
When gonads talk to the heart sex hormones and cardiac endocrine function., file dd9e0b31-bf83-709e-e053-3705fe0a83fd
|
126
|
|
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis, file dd9e0b32-620e-709e-e053-3705fe0a83fd
|
124
|
|
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications, file dd9e0b31-bf2a-709e-e053-3705fe0a83fd
|
120
|
|
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy., file dd9e0b31-cb10-709e-e053-3705fe0a83fd
|
109
|
|
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology, file 5ff83d81-2ace-40aa-ab48-e40036186ca0
|
102
|
|
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver
disease., file dd9e0b31-c0d2-709e-e053-3705fe0a83fd
|
102
|
|
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP, file dd9e0b31-c183-709e-e053-3705fe0a83fd
|
95
|
|
Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology, file dd9e0b32-63f0-709e-e053-3705fe0a83fd
|
93
|
|
State of the art of aldosterone immunoassays., file dd9e0b31-cb12-709e-e053-3705fe0a83fd
|
91
|
|
RNA-targeting and gene editing therapies for transthyretin amyloidosis, file c6c41c7e-fe0e-49ef-9a83-337fdaad0ef3
|
85
|
|
Natriuretic Peptide assays revisited do we need pro-B-type natriuretic Peptide?, file dd9e0b31-be83-709e-e053-3705fe0a83fd
|
83
|
|
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients, file dd9e0b31-bcd9-709e-e053-3705fe0a83fd
|
75
|
|
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals, file dd9e0b31-bfd1-709e-e053-3705fe0a83fd
|
74
|
|
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review, file dd9e0b31-bf2c-709e-e053-3705fe0a83fd
|
71
|
|
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex, file dd9e0b31-bff9-709e-e053-3705fe0a83fd
|
66
|
|
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis, file dd9e0b32-5945-709e-e053-3705fe0a83fd
|
66
|
|
Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction, file dd9e0b32-628a-709e-e053-3705fe0a83fd
|
66
|
|
Endocrine paradox in heart failure: resistance to biological effetcs of cardiac natriuretic hormones, file dd9e0b31-bc27-709e-e053-3705fe0a83fd
|
64
|
|
Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study., file dd9e0b31-c0d5-709e-e053-3705fe0a83fd
|
62
|
|
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy, file dd9e0b31-bf38-709e-e053-3705fe0a83fd
|
60
|
|
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides., file dd9e0b31-d0b4-709e-e053-3705fe0a83fd
|
60
|
|
The triglyceride/HDL cholesterol ratio and TyG index predict coronary atherosclerosis and outcome in the general population, file 83dd5d23-4e04-4550-a64c-3faf9541b1e0
|
58
|
|
Assessing Cardiac Response to Patisiran by Changes in Extracellular Volume: Potential Issues, file dd9e0b32-62c1-709e-e053-3705fe0a83fd
|
58
|
|
Surgery casualties: do not leave hearts behind enemy lines, file dd9e0b31-c138-709e-e053-3705fe0a83fd
|
55
|
|
Biomarkers for the diagnosis and management of heart failure, file dd9e0b32-5ab8-709e-e053-3705fe0a83fd
|
54
|
|
Unravelling the role of sex in the pathophysiology, phenotypic expression and diagnosis of cardiac amyloidosis, file 7d579d2a-530c-4c89-8b46-abf05c400a51
|
49
|
|
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review, file dd9e0b31-bc26-709e-e053-3705fe0a83fd
|
49
|
|
High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis, file 3204f6f5-df7e-4729-8cfd-d7369da3d939
|
46
|
|
Prediction of the chemoreflex gain by common clinical variables in heart failure, file dd9e0b32-36f1-709e-e053-3705fe0a83fd
|
46
|
|
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets, file dd9e0b32-6304-709e-e053-3705fe0a83fd
|
45
|
|
Post-mortem CMR in a model of sudden death due to myocardial ischemia: validation with connexin-43, file 71d6ed02-a2dc-47cb-be1a-0c2f645d9134
|
41
|
|
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure, file dd9e0b31-bdc7-709e-e053-3705fe0a83fd
|
40
|
|
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population, file 4953cbfb-c35b-4092-bf09-6d1fe5ecf40d
|
38
|
|
Clinical relevance of biological variation of B-Type Natriuretic Peptide, file dd9e0b31-bc2c-709e-e053-3705fe0a83fd
|
38
|
|
Analytical performance and diagnostic accuracy of immunometricassays for the measurement of plasma BNP and NT-proBNP concentrations, file dd9e0b31-bc2b-709e-e053-3705fe0a83fd
|
36
|
|
The 'Peptide for Life' Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe, file 3250f832-1760-42cd-a2f1-a6984e33f6c8
|
35
|
|
Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide, file dd9e0b31-bc2d-709e-e053-3705fe0a83fd
|
35
|
|
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient, file dd9e0b32-6251-709e-e053-3705fe0a83fd
|
35
|
|
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction, file dd9e0b32-624b-709e-e053-3705fe0a83fd
|
34
|
|
Clinical management of drug-induced cardiotoxicity in patients with HER-2+ breast cancer: current recommendations and future outlook, file e7992fc3-ec84-4b25-9c62-05a7cd865698
|
33
|
|
Automated Electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals, file dd9e0b31-bc24-709e-e053-3705fe0a83fd
|
30
|
|
Evaluation of Analytical Performance of the Siemens ADVIA TnI Ultra Immunoassay, file dd9e0b31-bda7-709e-e053-3705fe0a83fd
|
28
|
|
Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is, file 09f33dd1-a8e8-4f1a-8ac5-8f86a88adf65
|
27
|
|
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis, file a7befd8b-ebc8-4830-8f7d-ab4486ddb98d
|
27
|
|
Speckle tracking echocardiography in heart failure development and progression in patients with apneas, file b368a2ba-213f-4379-997b-fb2e8a319202
|
27
|
|
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation, file 1b2839f4-de27-4957-820e-96850964333d
|
24
|
|
Baroreflex activation therapy in heart failure: targeting the right patient, file 745ee681-5429-40d1-b04e-7887091677cd
|
22
|
|
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure., file dd9e0b31-df04-709e-e053-3705fe0a83fd
|
22
|
|
Association between implantable defibrillator-detected sleep apnea and atrial fibrillation: The DASAP-HF study, file f06ebd09-c485-44f9-8633-3897d8bd9416
|
21
|
|
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences, file 9e637167-54d6-4d42-b2b4-db2a0b90334d
|
20
|
|
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism, file 0fc30176-24f9-43bc-85f3-761ec92c7a29
|
18
|
|
Sex-related difference in sympathetic chemoreflex response: does it matter in clinical disease?, file 4c94d8a2-3abf-49fc-91e5-c60cb52756af
|
17
|
|
Galectin-3 and Risk for Cancer or Heart Failure: Does Sex Matter?, file d413af62-8139-40d0-9f76-19b7233b7f77
|
15
|
|
Preclinical scenario of targeting myocardial fibrosis with chimeric antigen receptor (CAR) immunotherapy, file e15cb778-5187-4d02-8fb5-fcd7ea50a3fb
|
15
|
|
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc?, file 0821bb73-5b0f-4578-87ff-ac2d8adcf0af
|
14
|
|
Conventional heart failure therapy in cardiac ATTR amyloidosis, file 5e7c611b-477e-4fa5-8b3e-0120882d7756
|
14
|
|
Urinary NGAL in acute heart failure revisited: the game is not over yet, file aa7e39e7-0cbe-4d7b-b685-9115d8186c11
|
14
|
|
Sex-specific associations of myocardial perfusion imaging with outcomes in patients with suspected chronic coronary syndrome, file 032efd50-3172-4547-8fb6-20996408ecb6
|
13
|
|
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry, file 5129366f-bb93-4505-8937-3bbe366571d5
|
13
|
|
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register, file 66eb8f4c-12ac-43a3-bec9-86a3259eb703
|
13
|
|
Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma?, file a0a54c79-db27-4302-a3f6-5e1cb6690ffa
|
13
|
|
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance, file f1354527-602b-49e6-b1b9-991f0e1ab504
|
13
|
|
CMR predictors of secondary moderate to severe mitral regurgitation and its additive prognostic role in previous myocardial infarction, file 22577e8a-d207-42dc-9398-de654b5a1220
|
12
|
|
Etiology, clinical presentation, and management of left main coronary artery aneurysms, file 87f4c0ab-34ff-4cf2-99e7-28bdecfb92ef
|
12
|
|
Role of Imaging in Cardiomyopathies, file 93b245e0-ef43-43e5-8169-7c35ba1953fc
|
12
|
|
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study, file c4f88657-2613-43a5-9456-91a3a35f2cf1
|
12
|
|
Prognostic Value of sST2 in Heart Failure, file 20bd1de7-4d0f-45e8-ad03-2b9d94f72e6b
|
11
|
|
Management of complications of cardiac amyloidosis: 10 questions and answers, file 645f5784-6ac8-44a9-abc4-44da558ccb7b
|
11
|
|
Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry, file 26a97dca-9508-4944-bef8-ee0a3a929644
|
10
|
| Totale |
13.246 |